Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

Similar articles for PubMed (Select 12908662)

2.

Bridging the efficacy-effectiveness gap in the antipsychotic treatment of schizophrenia: back to the basics.

Tandon R.

J Clin Psychiatry. 2014 Nov;75(11):e1321-2. doi: 10.4088/JCP.14com09595. Review. No abstract available.

3.

Effectiveness of antipsychotic drugs against hostility in patients with schizophrenia in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study - ADDENDUM.

Volavka J, Czobor P, Citrome L, Van Dorn RA.

CNS Spectr. 2014 Oct;19(5):466. doi: 10.1017/S1092852914000364. Epub 2014 Jul 14. No abstract available.

PMID:
25017569
4.

A multiple imputation strategy for sequential multiple assignment randomized trials.

Shortreed SM, Laber E, Scott Stroup T, Pineau J, Murphy SA.

Stat Med. 2014 Oct 30;33(24):4202-14. doi: 10.1002/sim.6223. Epub 2014 Jun 11.

PMID:
24919867
5.

Set-valued dynamic treatment regimes for competing outcomes.

Laber EB, Lizotte DJ, Ferguson B.

Biometrics. 2014 Mar;70(1):53-61. doi: 10.1111/biom.12132. Epub 2014 Jan 8.

7.

Repeated randomization and matching in multi-arm trials.

Xu Z, Kalbfleisch JD.

Biometrics. 2013 Dec;69(4):949-59. doi: 10.1111/biom.12077. Epub 2013 Oct 17.

PMID:
24134592
8.

Life satisfaction among individuals with schizophrenia in the Clinical Antipsychotic Trial of Intervention Effectiveness (CATIE) study.

Fervaha G, Agid O, Takeuchi H, Foussias G, Remington G.

Am J Psychiatry. 2013 Sep;170(9):1061-2. doi: 10.1176/appi.ajp.2013.13010060. No abstract available.

PMID:
24030617
9.
10.

Practicing evidence-based psychiatry: 1. Applying a study's findings: The threats to validity approach.

Rankupalli B, Tandon R.

Asian J Psychiatr. 2010 Mar;3(1):35-40. doi: 10.1016/j.ajp.2010.01.002. Epub 2010 Mar 4.

PMID:
23051138
11.
12.

Mixtures of multiple testing procedures for gatekeeping applications in clinical trials.

Dmitrienko A, Tamhane AC.

Stat Med. 2011 Jun 15;30(13):1473-88. doi: 10.1002/sim.4008. Epub 2011 Apr 18.

PMID:
21503948
13.

A concise display of multiple end points for benefit-risk assessment.

Levitan B.

Clin Pharmacol Ther. 2011 Jan;89(1):56-9. doi: 10.1038/clpt.2010.251. Epub 2010 Nov 24. Erratum in: Clin Pharmacol Ther. 2011 Mar;89(3):468.

PMID:
21107317
14.

Reflecting heterogeneity in patient benefits: the role of subgroup analysis with comparative effectiveness.

Sculpher M.

Value Health. 2010 Jun;13 Suppl 1:S18-21. doi: 10.1111/j.1524-4733.2010.00750.x. No abstract available.

PMID:
20618790
15.

Cognitive Outcomes in the CATIE Schizophrenia Trial: Why do they seem different from previous results?

Harvey PD.

Psychiatry (Edgmont). 2007 Sep;4(9):20-3. No abstract available.

16.

Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report.

Coons SJ, Gwaltney CJ, Hays RD, Lundy JJ, Sloan JA, Revicki DA, Lenderking WR, Cella D, Basch E; ISPOR ePRO Task Force.

Value Health. 2009 Jun;12(4):419-29. doi: 10.1111/j.1524-4733.2008.00470.x. Epub 2008 Nov 11.

PMID:
19900250
17.

Trial that pays patients to take antipsychotic drugs comes under attack.

Eaton L.

BMJ. 2009 Oct 12;339:b4202. doi: 10.1136/bmj.b4202. No abstract available.

PMID:
19822620
18.

Clinical trials design lessons from the CATIE study.

Kraemer HC, Glick ID, Klein DF.

Am J Psychiatry. 2009 Nov;166(11):1222-8. doi: 10.1176/appi.ajp.2009.08121809. Epub 2009 Oct 1. Review.

PMID:
19797435
19.

Comparative effectiveness research for antipsychotic medications: how much is enough?

Meltzer DO, Basu A, Meltzer HY.

Health Aff (Millwood). 2009 Sep-Oct;28(5):w794-808. doi: 10.1377/hlthaff.28.5.w794. Epub 2009 Jul 21.

20.

[Atypical antipsychotics and CATIE-AD. Is this a turning point?].

Bustin J.

Vertex. 2009 Mar-Apr;20(84):136-43. Spanish.

PMID:
19543565
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk